Additive action of a novel Cathepsin K inhibitor and zoledronic acid (Zometa) in a model of osteolytic human breast cancer metastasis

https://hdl.handle.net/10779/DRO/DU:29878460

journal contribution

posted on 2025-08-11, 06:29 authored by M Waltham, N Sims, E Williams, A Connor, T Kalebic, J Zimmerman, E Thompson

Additive action of a novel Cathepsin K inhibitor and zoledronic acid (Zometa) in a model of osteolytic human breast cancer metastasis

History

Related Materials

1.
DOI - Is version of https://doi.org/10.1016/s1359-6349(06)70092-1

Open access

No

Language

eng

Publication classification

E3.1 Extract of paper

Journal

European Journal of Cancer Supplements

Volume

4

Pagination

30-30

ISSN

1359-6349

Issue

12

Publisher

Elsevier BV

Usage metrics

Categories

Keywords

Breast Cancer Cancer Women's Health

Licence

All Rights Reserved

Exports